Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000173393 | SCV000224502 | uncertain significance | not provided | 2015-02-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000173393 | SCV001724433 | benign | not provided | 2024-01-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002516583 | SCV003634335 | uncertain significance | Inborn genetic diseases | 2021-12-14 | criteria provided, single submitter | clinical testing | The c.134A>G (p.D45G) alteration is located in exon 1 (coding exon 1) of the PROM1 gene. This alteration results from a A to G substitution at nucleotide position 134, causing the aspartic acid (D) at amino acid position 45 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |